Toxicity and Functional Impairment in Human Adipose Tissue-Derived Stromal Cells (hASCs) Following Long-Term Exposure to Very Small Iron Oxide Particles (VSOPs).

VSOP differentiation potential human adipose-derived stromal cells iron oxide nanoparticles long-term exposure nanoparticles stem cells toxicity

Journal

Nanomaterials (Basel, Switzerland)
ISSN: 2079-4991
Titre abrégé: Nanomaterials (Basel)
Pays: Switzerland
ID NLM: 101610216

Informations de publication

Date de publication:
13 Apr 2020
Historique:
received: 04 03 2020
revised: 03 04 2020
accepted: 05 04 2020
entrez: 17 4 2020
pubmed: 17 4 2020
medline: 17 4 2020
Statut: epublish

Résumé

Magnetic nanoparticles (NPs), such as very small iron oxide NPs (VSOPs) can be used for targeted drug delivery, cancer treatment or tissue engineering. Another important field of application is the labelling of mesenchymal stem cells to allow in vivo tracking and visualization of transplanted cells using magnetic resonance imaging (MRI). For these NPs, however, various toxic effects, as well as functional impairment of the exposed cells, are described. The present study evaluates the influence of VSOPs on the multilineage differentiation ability and cytokine secretion of human adipose tissue derived stromal cells (hASCs) after long-term exposure. Human ASCs were labelled with VSOPs, and the efficacy of the labelling was documented over 4 weeks in vitro cultivation of the labelled cells. Unlabelled hASCs served as negative controls. Four weeks after labelling, adipogenic and osteogenic differentiation was histologically evaluated and quantified by polymerase chain reaction (PCR). Changes in gene expression of IL-6, IL-8, VEGF and caspase 3 were determined over 4 weeks. Four weeks after the labelling procedure, labelled and unlabelled hASCs did not differ in the gene expression of IL-6, IL-8, VEGF and caspase 3. Furthermore, the labelling procedure had no influence on the multidifferentiation ability of hASC. The percentage of labelled cells decreased during in vitro expansion over 4 weeks. Labelling with VSOPs and long-term intracellular disposition probably have no influence on the physiological functions of hASCs. This could be important for the future in vivo use of iron oxide NPs.

Identifiants

pubmed: 32294970
pii: nano10040741
doi: 10.3390/nano10040741
pmc: PMC7221569
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Interdisziplinäres Zentrum für Klinische Forschung, Universitätsklinikum Würzburg
ID : D-137

Références

Toxicol Lett. 2012 Apr 5;210(1):53-63
pubmed: 22269213
Rofo. 2005 Aug;177(8):1151-63
pubmed: 16021549
Discov Med. 2015 Apr;19(105):245-53
pubmed: 25977187
Nanomedicine (Lond). 2016 Aug;11(15):1957-70
pubmed: 27456272
Cytotherapy. 2006;8(2):166-77
pubmed: 16698690
Cytotherapy. 2013 Jul;15(7):767-81
pubmed: 23643417
Stem Cell Res Ther. 2013 Apr 23;4(2):44
pubmed: 23618360
J Immunol Methods. 1983 Dec 16;65(1-2):55-63
pubmed: 6606682
Plast Reconstr Surg. 2020 Feb;145(2):409-418
pubmed: 31985633
Biochem Biophys Res Commun. 2015 Dec 18;468(3):463-70
pubmed: 26271592
NMR Biomed. 2004 Nov;17(7):513-7
pubmed: 15526348
Dermatol Surg. 2008 Sep;34(9):1178-85
pubmed: 18513295
Int J Nanomedicine. 2019 Dec 06;14:9677-9692
pubmed: 31827324
Nanomedicine (Lond). 2006 Aug;1(2):157-68
pubmed: 17716105
J Oral Pathol Med. 2019 Oct;48(9):803-809
pubmed: 31309616
Int J Nanomedicine. 2010 Nov 16;5:983-9
pubmed: 21187917
PLoS One. 2010 Jul 07;5(7):e11462
pubmed: 20628641
Biomaterials. 2008 Apr;29(10):1473-83
pubmed: 18155133
Toxicol Appl Pharmacol. 2010 Jun 1;245(2):272-9
pubmed: 20338187
Int J Oncol. 2015 Jul;47(1):391-7
pubmed: 25997536
Cell Death Dis. 2016 Oct 27;7(10):e2441
pubmed: 27787519
Cell Biol Int. 2015 Aug;39(8):899-909
pubmed: 25759304
Mol Med Rep. 2012 Feb;5(2):317-20
pubmed: 22011913
Front Neurosci. 2019 Oct 11;13:1092
pubmed: 31680827
PLoS One. 2013 May 08;8(5):e62644
pubmed: 23667503
Expert Opin Drug Deliv. 2013 Jan;10(1):73-87
pubmed: 23199200
Biomed Pharmacother. 2019 Jun;114:108765
pubmed: 30921703
PLoS One. 2014 Sep 22;9(9):e108055
pubmed: 25244560
Mol Biol Cell. 2002 Dec;13(12):4279-95
pubmed: 12475952
J Orthop Res. 2002 Sep;20(5):1060-9
pubmed: 12382974
Laryngorhinootologie. 2014 Jun;93(6):369-80
pubmed: 24863908
Science. 1999 Apr 2;284(5411):143-7
pubmed: 10102814
Tissue Eng. 2006 Dec;12(12):3375-82
pubmed: 17518674
J Biosci Bioeng. 2005 Jul;100(1):1-11
pubmed: 16233845
Biomaterials. 2011 Jan;32(1):195-205
pubmed: 20863560
J Cell Biochem. 1997 Feb;64(2):295-312
pubmed: 9027589
Int J Artif Organs. 2012 Dec;35(12):1047-60
pubmed: 23065876
Cells Tissues Organs. 2013;197(5):384-98
pubmed: 23485626
Mol Imaging. 2009 May-Jun;8(3):166-78
pubmed: 19723474
Nano Rev. 2010;1:
pubmed: 22110864
Toxicol Lett. 2011 Feb 25;201(1):27-33
pubmed: 21145381
Materials (Basel). 2019 Jun 05;12(11):
pubmed: 31195623
Free Radic Biol Med. 2004 Apr 15;36(8):976-84
pubmed: 15059638
Environ Health Perspect. 2005 Jul;113(7):823-39
pubmed: 16002369
J Tissue Eng Regen Med. 2016 Oct;10(10):E409-E418
pubmed: 24170732
Environ Health Perspect. 2007 Mar;115(3):403-9
pubmed: 17431490
Int J Environ Res Public Health. 2017 Dec 18;14(12):
pubmed: 29258234
Int J Mol Sci. 2013 Jul 31;14(8):15910-30
pubmed: 23912234
Tissue Eng Part A. 2019 Nov;25(21-22):1470-1477
pubmed: 30747035
J Biomed Nanotechnol. 2013 Jan;9(1):86-95
pubmed: 23627071
Biol Trace Elem Res. 2014 Jun;159(1-3):416-24
pubmed: 24748114
Nanomedicine (Lond). 2007 Feb;2(1):23-39
pubmed: 17716188
Toxicol In Vitro. 2011 Apr;25(3):657-63
pubmed: 21232592
Curr Opin Pharmacol. 2014 Oct;18:18-27
pubmed: 25173782
Respir Med. 2007 Jun;101(6):1155-62
pubmed: 17280825

Auteurs

Katrin Radeloff (K)

Department of Otorhinolaryngology, Head and Neck Surgery, Evangelisches Krankenhaus, Carl von Ossietzky-University, 26129 Oldenburg, Germany.

Andreas Radeloff (A)

Department of Otorhinolaryngology, Head and Neck Surgery, Evangelisches Krankenhaus, Carl von Ossietzky-University, 26129 Oldenburg, Germany.

Mario Ramos Tirado (M)

Department of Otorhinolaryngology, Plastic, Aesthetic and Reconstructive Head and Neck Surgery, Julius-Maximilian-University, 97070 Würzburg, Germany.

Agmal Scherzad (A)

Department of Otorhinolaryngology, Plastic, Aesthetic and Reconstructive Head and Neck Surgery, Julius-Maximilian-University, 97070 Würzburg, Germany.

Rudolf Hagen (R)

Department of Otorhinolaryngology, Plastic, Aesthetic and Reconstructive Head and Neck Surgery, Julius-Maximilian-University, 97070 Würzburg, Germany.

Norbert H Kleinsasser (NH)

Department of Otorhinolaryngology, Head and Neck Surgery, Kepler-University, 4040 Linz, Austria.

Stephan Hackenberg (S)

Department of Otorhinolaryngology, Plastic, Aesthetic and Reconstructive Head and Neck Surgery, Julius-Maximilian-University, 97070 Würzburg, Germany.

Classifications MeSH